← Back to Search

Enhanced Care for Smoking Cessation

N/A
Waitlist Available
Led By Kenneth M Cummings, PhD
Research Sponsored by Medical University of South Carolina
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
18+ years and older
Be older than 18 years old
Must not have
Those unable to communicate in the English language
Timeline
Screening 3 weeks
Treatment Varies
Follow Up assessed 6-weeks post-discharge
Awards & highlights
No Placebo-Only Group

Summary

This trialaims to replicate a successful smoking cessation program in 3 different patient groups to help them quit smoking.

Who is the study for?
This trial is for hospitalized cigarette smokers over the age of 18 who are being discharged back to their homes. Participants must have a phone number and be able to communicate in English. It's not open to those without a phone or who can't speak English.
What is being tested?
The study is testing two types of smoking cessation services: Basic Care and Enhanced Care, across different patient groups including psychiatric inpatients and non-psychiatric patients at various hospitals affiliated with MUSC.
What are the potential side effects?
Since this trial focuses on smoking cessation services rather than medication, it does not list specific side effects like drug trials do. However, quitting smoking can lead to withdrawal symptoms such as irritability, cravings, and difficulty concentrating.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 18 years old or older.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I cannot communicate in English.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~assessed 6-weeks post-discharge
This trial's timeline: 3 weeks for screening, Varies for treatment, and assessed 6-weeks post-discharge for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Self-reported smoking prevalence 6-weeks after hospitalization.
Self-reported use of FDA Approved Smoking Cessation Medication

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Enhanced Care ConditionExperimental Treatment1 Intervention
Group II: Basic Care ConditionActive Control1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Enhanced Care
2010
Completed Phase 4
~1320

Find a Location

Who is running the clinical trial?

Medical University of South CarolinaLead Sponsor
971 Previous Clinical Trials
7,398,075 Total Patients Enrolled
Kenneth M Cummings, PhDPrincipal Investigator - Medical University of South Carolina
Medical University of South Carolina

Media Library

Basic Care Clinical Trial Eligibility Overview. Trial Name: NCT04827914 — N/A
Smoking Cessation Research Study Groups: Enhanced Care Condition, Basic Care Condition
Smoking Cessation Clinical Trial 2023: Basic Care Highlights & Side Effects. Trial Name: NCT04827914 — N/A
Basic Care 2023 Treatment Timeline for Medical Study. Trial Name: NCT04827914 — N/A
~25 spots leftby Jan 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top